Chemed (NYSE:CHE) Updates FY24 Earnings Guidance

Chemed (NYSE:CHEGet Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $23.55-23.80 for the period, compared to the consensus EPS estimate of $23.21. Chemed also updated its FY 2024 guidance to 23.550-23.800 EPS.

Chemed Trading Down 1.2 %

NYSE CHE traded down $6.51 on Thursday, reaching $540.97. The stock had a trading volume of 225,113 shares, compared to its average volume of 85,353. The company has a market capitalization of $8.19 billion, a price-to-earnings ratio of 30.44, a P/E/G ratio of 2.23 and a beta of 0.43. Chemed has a 1 year low of $492.84 and a 1 year high of $654.62. The business has a 50 day moving average price of $544.12 and a 200 day moving average price of $583.59.

Chemed (NYSE:CHEGet Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a return on equity of 30.52% and a net margin of 12.36%. The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same quarter in the prior year, the company posted $4.71 earnings per share. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, analysts anticipate that Chemed will post 21.54 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were issued a $0.40 dividend. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.60 annualized dividend and a yield of 0.30%. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Royal Bank of Canada decreased their target price on Chemed from $712.00 to $697.00 and set an outperform rating for the company in a research note on Tuesday, May 21st. StockNews.com upgraded Chemed from a hold rating to a buy rating in a research report on Saturday, May 4th.

Get Our Latest Report on Chemed

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the sale, the chief executive officer now owns 108,549 shares in the company, valued at $61,605,899.46. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, CEO Kevin J. Mcnamara sold 4,000 shares of Chemed stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $567.54, for a total transaction of $2,270,160.00. Following the completion of the sale, the chief executive officer now directly owns 108,549 shares of the company’s stock, valued at $61,605,899.46. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the company’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the sale, the chief executive officer now directly owns 107,049 shares of the company’s stock, valued at $58,252,854.33. The disclosure for this sale can be found here. Insiders have sold a total of 5,784 shares of company stock worth $3,240,053 in the last 90 days. Corporate insiders own 3.32% of the company’s stock.

About Chemed

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Earnings History and Estimates for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.